LGNZZLigand Pharmaceuticals Incorporated

About Ligand Pharmaceuticals Incorporated (LGNZZ)

Ligand Pharmaceuticals Incorporated (LGNZZ) is a N/A company headquartered in Jupiter, FL, United States whose shares trade over-the-counter on the Pink tier.

Ligand discovers, develops and markets new drugs for critical unmet medical needs in the areas of cancer, pain, skin diseases, hormone-related diseases, osteoporosis, metabolic disorders, cardiovascular and inflammatory diseases. Ligand's proprietary drug discovery and development programs are based on its leadership position in gene transcription technology related to intracellular receptors.

LGNZZ key facts

Ticker symbol

LGNZZ

Market tier

Pink

Headquarters

Jupiter, FL, United States

Country of incorporation

US

Year of incorporation

1987

Employees

550

Reporting standard

U.S. Reporting: SEC Reporting

Audit status

Audited

Fiscal year end

12/31

Ligand Pharmaceuticals Incorporated leadership

• David A. Robinson — President, CEO
• Matthew A. Foehr — President, COO
• John Higgins — President, CEO
• Nishan de Silva — CFO
• Matthew Korenberg — CFO, VP, Fin., Principal Acct. Officer
• Charles A. Berkman — Vice President, Secretary, General Counsel
• Erika Luib — IR

Explore more: Pink stocks · OTC stocks starting with L